人参灵芝鱼胶液治疗肿瘤相关性厌食临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R273

基金项目:

粤港澳中医药与免疫疾病研究联合实验室(2020B1212030006);广州地区中西医协同临床重大创新技术建设项目(穗卫函〔2023〕2318号)


Clinical Study on Renshen Lingzhi Yujiao Liquid for Anorexia Related with Tumor
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察人参灵芝鱼胶液治疗肿瘤相关性厌食的临床疗效。方法:选取2020年12月—2021年 12月广东省中医院收治的接受化疗或化疗联合靶向治疗的45例肿瘤相关性厌食患者,按随机数字表法分为中 药组、西药组、对照组各15例。治疗过程中西药组脱落5例,最终中药组、对照组各15例,西药组10例。中 药组口服人参灵芝鱼胶液治疗,西药组口服醋酸甲地孕酮分散片治疗,对照组不予干预措施。3组均治疗 6周。观察3组不良反应发生情况,比较3组治疗前后食欲视觉模拟评分法(VAS) 评分、埃德蒙顿症状评估量 表(ESAS) 评分、血红蛋白、白细胞、血小板等实验室检查指标值的变化。结果:中药组食欲VAS评分治疗 6周后与治疗前比较,差异有统计学意义(P<0.05)。治疗前,治疗6周后,3组组内、组间比较,差异均无统 计学意义(P>0.05)。ESAS评分组内及组间比较,差异均无统计学意义(P>0.05);血红蛋白、白细胞治疗 前后差值组间比较差异有统计学意义(P<0.05)。治疗6周后,中药组血红蛋白差值高于西药组(P<0.05), 对照组血红蛋白差值高于西药组(P<0.05);中药组白细胞差值高于对照组(P<0.05)。在抗肿瘤治疗相关不 良反应方面,无3/4级不良反应发生(P>0.05)。结论:人参灵芝鱼胶液能够改善肿瘤相关性厌食症状,提升 免疫力,有改善骨髓抑制。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Renshen Lingzhi Yujiao Liquid for anorexia related with tumor. Methods:A total of 45 patients with anorexia related with tumor who received chemotherapy or chemotherapy combined with targeted therapy at Guangdong Provincial Hospital of Chinese Medicine from December 2020 to December 2021 were selected and divided into the Chinese medicine group, the western medicine group, and the control group,with 15 patients in each group according to random number table method. During the treatment process,five cases were dropped from the western medicine group,ultimately with 15 cases in the Chinese medicine group and 15 cases in the control group, and 10 cases in the western medicine group. The Chinese medicine group was orallytreated with Renshen Lingzhi Yujiao Liquid, and the western medicine group was treated with oral administration olMedroxyprogesterone Acetate Dispersible Tablets. The control group did not receive any intervention measures. All threegroups were treated for six weeks. 0bserved the occurenee of adverse reaclions in three groups and compared thechanges in Visual Analogue Seale (VAS)of appetite, Edmonton Symptom Assessment Seale (ESAS) scores.hemoglobin, white blood cells, platelets and other laboratory test indicators before and after treatment in the threegroups.Results : There was significant difference in the comparison of the VAS scores of appelite aller six weeks of trealmentand belfore trealment in the Chinese medieine group ( P< 0.05 ). while no statistically signiicant dilferenees were presentedin the comparison of the VAS seores of appetite belore treatment and alter six weeks of treatment among the three groups( P> 0.05 ) . There was no significant diference in the intra group and inter group comparisons of ESAS scores(P >0.05 );however , the diflerence in hemoglobin and white blood cell levels before and alter treatment showed significance whencompared among the three groups ( p < 0.05 ). After six weeks of treatment, the differenee between the hemoglobinlevel of the Chinese medicine group was higher than the westem medicine group (p < 0.05), and the dilference between thecontrol group was higher than that of the western medicine group(p< 0.05); the diference between white blood cell levelof the Chinese medicine group was higher than the conlrol group (p < 0.05). In terms of adverse reactions related to anti-tumor therapy , no grade3 or 4 adverse reactions occurred ( P>0.05). Conclusion : Renshen Lingzhi Yujiao Liquidcan improve symptom of anorexia related with tumor, enhanee immunity , and have the elfect of improving bone marrowsuppression

    参考文献
    相似文献
    引证文献
引用本文

吴泽霞,常雪松,刘译鸿,张海波,朱燕娟,何怡瀚,余娅娅,肖真真,陈亚栋.人参灵芝鱼胶液治疗肿瘤相关性厌食临床研究[J].新中医,2025,57(5):136-140

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-17
  • 出版日期:
文章二维码